Literature DB >> 21045306

Purification, crystallization and preliminary X-ray analysis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase of Streptococcus pneumoniae.

Liping Zhang1, Lingling Feng, Li Zhou, Jie Gui, Jian Wan, Xiaopeng Hu.   

Abstract

Class II 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductases are potential targets for novel antibiotic development. In order to obtain a precise structural model for use in virtual screening and inhibitor design, HMG-CoA reductase of Streptococcus pneumoniae was cloned, overexpressed and purified to homogeneity using Ni-NTA affinity chromatography. Crystals were obtained using the hanging-drop vapour-diffusion method. A complete data set was collected from a single frozen crystal on a home X-ray source. The crystal diffracted to 2.3 Å resolution and belonged to the orthorhombic space group C222(1), with unit-cell parameters a = 773.4836, b = 90.3055, c = 160.5592 Å, α = β = γ = 90°. Assuming the presence of two molecules in the asymmetric unit, the solvent content was estimated to be 54.1% (V(M) = 2.68 Å(3) Da(-1)).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045306      PMCID: PMC3001659          DOI: 10.1107/S1744309110036481

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Structural mechanism for statin inhibition of HMG-CoA reductase.

Authors:  E S Istvan; J Deisenhofer
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

Authors:  P R Hebert; J M Gaziano; K S Chan; C H Hennekens
Journal:  JAMA       Date:  1997 Jul 23-30       Impact factor: 56.272

3.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 5.  Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases.

Authors:  Matija Hedl; Lydia Tabernero; Cynthia V Stauffacher; Victor W Rodwell
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 6.  Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials.

Authors:  D A Eisenberg
Journal:  Am J Med       Date:  1998-02-23       Impact factor: 4.965

7.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

8.  Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  L Tabernero; D A Bochar; V W Rodwell; C V Stauffacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  D A Bochar; C V Stauffacher; V W Rodwell
Journal:  Mol Genet Metab       Date:  1999-02       Impact factor: 4.797

10.  Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.

Authors:  Matija Hedl; Victor W Rodwell
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

View more
  1 in total

1.  Studies on the antibacterial effects of statins--in vitro and in vivo.

Authors:  Peter Bergman; Charlotte Linde; Katrin Pütsep; Anton Pohanka; Staffan Normark; Birgitta Henriques-Normark; Jan Andersson; Linda Björkhem-Bergman
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.